| 3U01AG010483-21S1 |
2012 |
$6081533 |
None |
ALZHEIMER'S DISEASE COOPERATIVE STUDY (ADCS) |
Aisen, Paul |
| 5U01AG010483-21 |
2011 |
$2057588 |
9003 |
ADMINISTRATIVE AND MEDICAL CORE (AMC) |
SALMON, DAVID P |
| 5U01AG010483-21 |
2011 |
$5798687 |
None |
ALZHEIMER'S DISEASE COOPERATIVE STUDY (ADCS) |
Aisen, Paul |
| 5U01AG010483-21 |
2011 |
$3041251 |
9004 |
DATA CORE (DC) |
THOMAS, RONALD G. |
| 5U01AG010483-21 |
2011 |
$566116 |
12 |
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE; MCI AND AD |
SANO, MARY |
| 5U01AG010483-21 |
2011 |
$133732 |
9005 |
RECRUITMENT CORE (RC) |
SANO, MARY |
| 5U01AG010483-20 |
2010 |
$7233659 |
None |
ALZHEIMER'S DISEASE COOPERATIVE STUDY (ADCS) |
Aisen, Paul |
| 5U01AG010483-20 |
2010 |
$2852722 |
9004 |
DATA CORE (DC) |
THOMAS, RONALD G. |
| 5U01AG010483-20 |
2010 |
$633478 |
13 |
EFFECTS OF DOCOSAHEXAENOIC ACID (DHA) IN SLOWING THE PROGRESSION OF AD (DHA) |
QUINN, JOSEPH F |
| 5U01AG010483-20 |
2010 |
$974570 |
12 |
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE; MCI AND AD |
SANO, MARY |
| 5U01AG010483-20 |
2010 |
$33834 |
15 |
INTRAVENOUS IMMUNOGLOBULIN (IVIG) FOR TREATMENT OF AD (IVIG) |
RELKIN, NORMAN R. |
| 5U01AG010483-20 |
2010 |
$136104 |
9005 |
RECRUITMENT CORE (RC) |
SANO, MARY |
| 5U01AG010483-20 |
2010 |
$488012 |
14 |
A TRIAL OF TTP488 TO SLOW THE RATE OF CLINICAL PROGRESSION OF PATIENTS WITH AD |
GALASKO, DOUGLAS R |
| 5U01AG010483-20 |
2010 |
$2114939 |
9003 |
ADMINISTRATIVE AND MEDICAL CORE (AMC) |
SALMON, DAVID P |
| 5U01AG010483-19 |
2009 |
$1362818 |
14 |
A TRIAL OF TTP488 TO SLOW THE RATE OF CLINICAL PROGRESSION OF PATIENTS WITH AD |
GALASKO, DOUGLAS R |
| 5U01AG010483-19 |
2009 |
$2176795 |
9003 |
ADMINISTRATIVE AND MEDICAL CORE (AMC) |
SALMON, DAVID P |
| 5U01AG010483-19 |
2009 |
$2871567 |
9004 |
DATA CORE (DC) |
THOMAS, RONALD G. |
| 5U01AG010483-19 |
2009 |
$1209491 |
13 |
EFFECTS OF DOCOSAHEXAENOIC ACID (DHA) IN SLOWING THE PROGRESSION OF AD (DHA) |
QUINN, JOSEPH F |
| 5U01AG010483-19 |
2009 |
$1178119 |
12 |
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE; MCI AND AD |
SANO, MARY |
| 5U01AG010483-19 |
2009 |
$707426 |
15 |
INTRAVENOUS IMMUNOGLOBULIN (IVIG) FOR TREATMENT OF AD (IVIG) |
RELKIN, NORMAN R. |
| 5U01AG010483-19 |
2009 |
$131876 |
9005 |
RECRUITMENT CORE (RC) |
SANO, MARY |
| 5U01AG010483-18 |
2008 |
$1517318 |
14 |
A TRIAL OF TTP488 TO SLOW THE RATE OF CLINICAL PROGRESSION OF PATIENTS WITH AD |
GALASKO, DOUGLAS R |
| 5U01AG010483-18 |
2008 |
$2288186 |
9004 |
DATA CORE (DC) |
THOMAS, RONALD G. |
| 5U01AG010483-18 |
2008 |
$1647782 |
13 |
EFFECTS OF DOCOSAHEXAENOIC ACID (DHA) IN SLOWING THE PROGRESSION OF AD (DHA) |
QUINN, JOSEPH F |
| 5U01AG010483-18 |
2008 |
$946004 |
12 |
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE; MCI AND AD |
SANO, MARY |
| 5U01AG010483-18 |
2008 |
$1103923 |
15 |
INTRAVENOUS IMMUNOGLOBULIN (IVIG) FOR TREATMENT OF AD (IVIG) |
RELKIN, NORMAN R. |
